Gene · 51129
Papers4,105
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,105
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diabetic retinopathy: Research advances in canonical cellular pathways and emerging mechanisms. | Exp Eye Res | 2026 | 41985866 | PubTator, text mining | PubMed |
| Blood-based biomarker discovery for early pregnancy loss using integrative multi-omics strategies. | EBioMedicine | 2026 | 41980480 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Promote Tumor Immunosuppression in Hepatocellular Carcinoma via the NNMT-ANGPTL4 Axis. | Adv Sci (Weinh) | 2026 | 41980209 | PubTator, text mining | PubMed |
| Revealing key genes and molecular mechanisms associated with dietary restriction in ulcerative colitis. | Front Mol Biosci | 2026 | 41959722 | PubTator, text mining | PubMed |
| PIK3CA mutation-induced immune microenvironment remodeling sensitizes cervical cancer to immunotherapy. | Front Immunol | 2026 | 41958669 | PubTator, text mining | PubMed |
| Methylation and expression dynamics in broiler liver following in-ovo sodium butyrate administration. | J Vet Res | 2026 | 41953747 | PubTator, text mining | PubMed |
| Multiomics and multi-region spatial transcriptome analysis reveal cellular networks and pathways associated with HCC recurrence. | JHEP Rep | 2026 | 41950768 | PubTator, text mining | PubMed |
| Targeted Therapies in Infantile Hemangiomas and Vascular Malformations: From β-Blockers to PI3K/AKT/mTOR Inhibitors. | J Cell Mol Med | 2026 | 41928438 | PubTator, text mining | PubMed |
| Tumor exosomes impact functional hallmarks of cancer. | Cancer Metastasis Rev | 2026 | 41912733 | PubTator, text mining | PubMed |
| Dysregulated eating behaviour and microbiota-based interventions targeting eating disorders and food addiction. | Gut Microbes | 2026 | 41906418 | PubTator, text mining | PubMed |
| Identification of biomarkers associated with endoplasmic reticulum stress-related cell death in osteoporosis based on bulk and single-cell transcriptomic analyses and experimental validation. | Sci Rep | 2026 | 41905994 | PubTator, text mining | PubMed |
| New Frontiers in the Pathophysiology of Hypertensive Pregnancy Disorders: A Systematic Review of Molecular Insights into Preeclampsia. | Curr Issues Mol Biol | 2026 | 41899446 | PubTator, text mining | PubMed |
| RelA Signaling in Scgb1a1+ Progenitors Mediates Lower Airway Epithelial Atypia in RSV-Induced Post-Viral Lung Disease. | Int J Mol Sci | 2026 | 41898720 | PubTator, text mining | PubMed |
| The association between lipid metabolism and coronary artery disease: A systematic Mendelian randomization study combined with transcriptome analysis. | Medicine (Baltimore) | 2026 | 41894294 | PubTator, text mining | PubMed |
| Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer. | Proc Natl Acad Sci U S A | 2026 | 41886374 | PubTator, text mining | PubMed |
| ANGPTL4-dependent metabolic reprogramming fuels RhoA signalling and microvascular dysfunction in diabetes. | Acta Diabetol | 2026 | 41870639 | PubTator, text mining | PubMed |
| ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis. | Neoplasia | 2026 | 41864037 | PubTator, text mining | PubMed |
| Brain neuronal CG9593/ANGPTL4 activation mediates paternally acquired motor disorders. | Sci Adv | 2026 | 41861009 | PubTator, text mining | PubMed |
| Impact of angiopoietin-like 4 (ANGPTL4) protein and O-linked β-N-acetylglucosamine(O-GlcNAc) in diabetic nephropathy. | Diabetes Res Clin Pract | 2026 | 41833781 | PubTator, text mining | PubMed |
Synergistic inhibition of macular vascular permeability in diabetic edema: Ginsenoside Rg3 enhances ranibizumab efficacy by targeting angiopoietin-like protein 4 and vascular endothelial growth factor via neuropilin/RhoA signaling. | J Diabetes Investig | 2026 | 41830319 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51129/papers?page=4